X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Bajaj Finance with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAJAJ FINANCE vs INDOCO REMEDIES - Comparison Results

BAJAJ FINANCE    Change

Established in 1987, Bajaj Finance Ltd is a subsidiary of Bajaj Finserv Ltd, the financial services arm of the Bajaj Group. In the early days, Bajaj Finance provided loans for two and three-wheelers manufactured by Bajaj Auto Ltd. Over the years, the... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAJAJ FINANCE INDOCO REMEDIES BAJAJ FINANCE/
INDOCO REMEDIES
 
P/E (TTM) x 47.5 43.7 108.8% View Chart
P/BV x 16.9 2.8 613.2% View Chart
Dividend Yield % 1.1 0.8 130.6%  

Financials

 BAJAJ FINANCE   INDOCO REMEDIES
EQUITY SHARE DATA
    BAJAJ FINANCE
Mar-16
INDOCO REMEDIES
Mar-17
BAJAJ FINANCE/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs6,877360 1,908.2%   
Low Rs3,990249 1,601.6%   
Sales per share (Unadj.) Rs1,355.9119.0 1,139.2%  
Earnings per share (Unadj.) Rs237.38.4 2,837.7%  
Cash flow per share (Unadj.) Rs247.815.2 1,626.9%  
Dividends per share (Unadj.) Rs25.001.60 1,562.5%  
Dividend yield (eoy) %0.50.5 87.6%  
Book value per share (Unadj.) Rs1,378.670.7 1,949.8%  
Shares outstanding (eoy) m53.8792.15 58.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x4.02.6 156.5%   
Avg P/E ratio x22.936.4 62.8%  
P/CF ratio (eoy) x21.920.0 109.6%  
Price / Book Value ratio x3.94.3 91.4%  
Dividend payout %10.519.1 55.1%   
Avg Mkt Cap Rs m292,69228,083 1,042.2%   
No. of employees `0007.46.0 122.5%   
Total wages/salary Rs m6,2962,167 290.6%   
Avg. sales/employee Rs Th9,878.71,817.0 543.7%   
Avg. wages/employee Rs Th851.5359.0 237.2%   
Avg. net profit/employee Rs Th1,729.1127.7 1,354.2%   
INCOME DATA
Net Sales Rs m73,04310,968 666.0%  
Other income Rs m79240 1,994.2%   
Total revenues Rs m73,83511,007 670.8%   
Gross profit Rs m48,6861,565 3,111.7%  
Depreciation Rs m563633 89.0%   
Interest Rs m29,26962 47,131.4%   
Profit before tax Rs m19,646909 2,160.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,861139 4,946.3%   
Profit after tax Rs m12,785771 1,658.9%  
Gross profit margin %66.714.3 467.2%  
Effective tax rate %34.915.3 229.0%   
Net profit margin %17.57.0 249.1%  
BALANCE SHEET DATA
Current assets Rs m205,2605,725 3,585.5%   
Current liabilities Rs m130,5265,454 2,393.2%   
Net working cap to sales %102.32.5 4,145.4%  
Current ratio x1.61.0 149.8%  
Inventory Days Days062 0.0%  
Debtors Days Days89872 1,251.6%  
Net fixed assets Rs m2,8705,307 54.1%   
Share capital Rs m536184 290.6%   
"Free" reserves Rs m63,3966,331 1,001.3%   
Net worth Rs m74,2666,516 1,139.8%   
Long term debt Rs m252,8701,323 19,111.9%   
Total assets Rs m464,56511,970 3,881.2%  
Interest coverage x1.715.6 10.7%   
Debt to equity ratio x3.40.2 1,676.7%  
Sales to assets ratio x0.20.9 17.2%   
Return on assets %9.17.0 130.1%  
Return on equity %17.211.8 145.5%  
Return on capital %15.012.4 120.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m1481,141 13.0%   
Net fx Rs m-1483,366 -4.4%   
CASH FLOW
From Operations Rs m-97,932886 -11,048.2%  
From Investments Rs m-7,636-1,706 447.7%  
From Financial Activity Rs m116,5621,316 8,859.3%  
Net Cashflow Rs m10,995497 2,214.0%  

Share Holding

Indian Promoters % 61.6 59.2 104.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.1 12.5 56.8%  
FIIs % 12.2 6.0 203.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.1 22.4 85.3%  
Shareholders   19,952 12,805 155.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAJAJ FINANCE With:   KOTHARI PRODUCTS  STC INDIA  FINOLEX IND.  COMMEX TECHNOLOGY  INGERSOLL RAND  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3%

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

ICICI Securities IPO: Will the Brokerage Shine If Markets Don't? (IPO)

Mar 22, 2018

Is the IPO of one of India's first online brokerage firm, ICICI Securities, worth applying for?

Shriram Trans Fin: Expansion on Track Driven by Brisk Demand and Strong Earnings (Quarterly Results Update - Detailed)

Feb 16, 2018

Shriram Transport Finance puts up a strong performance on robust demand and falling credit costs.

HDFC: Listing Gains Mask Healthy Growth and Asset Quality (Quarterly Results Update - Detailed)

Feb 7, 2018

Windfall listing gains utilised to shore up provisions and strengthen balance sheet further.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BAJAJ FINANCE SHARE PRICE


Jun 22, 2018 (Close)

TRACK BAJAJ FINANCE

  • Track your investment in BAJAJ FINANCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BAJAJ FINANCE 8-QTR ANALYSIS

COMPARE BAJAJ FINANCE WITH

MARKET STATS